This award supports health services research addressing traumatic brain injury and psychological health outcomes in military populations. It seeks evidence-based studies to improve clinical care delivery and patient outcomes for service members.
This award supports clinical trials investigating health outcomes and treatments for service members exposed to toxic substances during military operations. The research aims to establish evidence-based interventions and improve medical care for affected veterans.
Develop advanced applied research concepts for naval space weather and plasma monitoring in the Southern Hemisphere. This challenge seeks game-changing dual-use capabilities that could accelerate Navy/Marine Corps operations while creating commercial and public benefits.
Develop AI-native air interface technology for tactical communication networks in a U.S.-India collaborative challenge. This applied research initiative seeks revolutionary dual-use concepts that could transform military communications and commercial applications.
Develop advanced communications and networking technologies to enable seamless, secure connectivity for distributed naval operations across manned and unmanned platforms. Address challenges like jamming, spectrum limitations, and infrastructure constraints to support real-time command and control.
Develop research resources, datasets, and infrastructure to advance rare cancers research and treatment outcomes. Supports patient tissue repositories, tumor models, data-sharing platforms, and community engagement strategies.
DoD seeks groundbreaking novel concepts to advance rare cancer research and treatment. This concept award supports highly innovative, untested ideas without requiring preliminary data, enabling early-stage exploration of potentially transformative approaches.
The Army seeks applied research innovations in orthopaedic medicine to advance soldier health and readiness. This award funds development of new treatments, devices, or technologies addressing musculoskeletal injuries and combat-related orthopedic conditions.
Seeking early-stage research to develop novel therapies for Duchenne muscular dystrophy across all age groups, from infants to nonambulatory individuals. High-risk/high-reward studies with strong preliminary data that could accelerate near-term clinical outcomes.
DoD seeks development of a multiomic atlas from human bone marrow failure samples to create an open-access research resource. This dataset will enable discoveries advancing understanding of bone marrow failure diseases across the research and clinical community.
This DoD funding supports early-stage rare cancer research ideas with potential for high-impact discoveries. The program welcomes exploratory approaches and accepts preliminary data from related disease studies to advance novel investigation pathways.
The Army seeks orthopaedic clinical research to advance musculoskeletal injury treatment and recovery for military personnel. This award funds innovative studies addressing combat-related and service-connected orthopaedic conditions.
Supports investigator-initiated research advancing bone marrow failure treatments through translational and clinical studies. Funds mature ideas with IND-enabling efforts and correlative research to drive significant patient care improvements.
Support innovative research to understand and cure bone marrow failure diseases through scientifically sound approaches. Open to established and early-career investigators; preliminary data not required.
Fund continuation of military medical R&D projects ranging from late-stage preclinical to clinical research that address Service Member health needs. Supports pharmaceutical, biologic, medical device, and technology development through clinical trials and translational studies.
Accelerate translational research in Duchenne muscular dystrophy toward clinical applications. DoD supports advanced preclinical and clinical studies with flexible funding levels and partnership options to bridge promising discoveries into therapies.
DoN seeks naval science and technology research from HBCUs/minority institutions, focusing on basic research that advances Navy/Marine Corps missions while building institutional research capacity and engaging students in STEM discovery.
This DoD program funds investigator-initiated research projects addressing key focus areas in Parkinson's disease, supporting rigorous multidisciplinary studies with potential for significant clinical impact. Clinical trials and collaborative research teams are welcome.
Support early-stage investigators conducting Parkinson's disease research through two funding levels, with mentorship for fellows and independent funding for early-career researchers. Proposed work must address priority research focus areas and advance understanding of PD mechanisms and interventions.
Develop high-impact ideas advancing kidney cancer understanding and patient outcomes through well-formulated research hypotheses. Supports single or partnered investigator teams with strong kidney cancer research backgrounds.
This DoD program mentors early-career kidney cancer researchers through intensive virtual training, peer networking, and personalized mentorship. It aims to develop the next generation of cutting-edge kidney cancer researchers and accelerate discovery of new patient treatments.
DARPA IPTO seeks revolutionary research ideas in information processing and computing that fall outside current programs. Proposals should address novel technical challenges with potential defense and national security applications.
Support for established neurofibromatosis researchers to lead a multi-institutional virtual academy mentoring early-career investigators. The program combines pilot research projects with structured mentorship to advance NF science and develop the next generation of research leaders.
This DOD program funds translational trauma care research that moves promising medical technologies from concept toward real-world solutions. Projects must demonstrate preliminary data and advance casualty survivability and point-of-injury care.
This award supports collaborative neurofibromatosis research teams (2-3 PIs) combining complementary expertise to tackle central NF problems. Applicants must demonstrate preliminary data and synergistic approaches to advance understanding and treatment of neurofibromatosis.